The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer
Clinical trial NCT01268163 · COMPLETED
Trial details
- NCT number
- NCT01268163
- Sponsor
- Hospira, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.